Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-29

Clinical Trial Update: A Study of the Safety and Efficacy of Anacetrapib (MK-0859) Among Participants With Hypercholesterolemia When Added to Ongoing Statin Therapy (MK-0859-022) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating safety and efficacy of anacetrapib (MK-0859) added to ongoing statin therapy in adults with hypercholesterolemia; study comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anacetrapib (anacetrapib)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED